Prof Research published a new market report on the Continuous Renal Replacement Therapy (CRRT) market. It presents the largest 11 manufacturers in the CRRT market. The report is a professional and in-depth study of the current state of the global CRRT market with a focus on the Chinese market. The report provides key statistics on the market of CRRT. It is a valuable source of guidance and direction for companies and individuals interested in the CRRT industry.

The global CRRT market was valued to be 1,618.9 million USD in 2021. The CRRT production value is anticipated to have grown with a CAGR of 5.34% in the coming years to reach 2,211.9  million USD in 2027.

Fresenius Medical Care is the largest manufacturer of CRRT in the world, it has a market share of 35.0% in value. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the Renal Care Continuum, the company focuses on expanding in complementary areas and in the field of critical care.

Baxter International is the second largest manufacturer of CRRT in the world, Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments, BioScience, Medication Delivery and Renal.

B. Braun is the third largest manufacturer of CRRT in the world, it has a market share of 9.9% in value. B. Braun develops, manufactures, and distributes medical technology and pharmaceutical products, and provides medical services. The company’s major products include solutions and consumables for infusion, disinfection products, infusion pumps and systems, nutrition and pain therapy, suture materials, hip and knee implants, surgical instruments, dialysis equipment and accessories, ostomy care and wound care products.

Medtronic is the fourth largest manufacturer of CRRT in the world, it has a market share of 7.4% in value. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices.